Home Insurers scrutinize drug costs after $84,000 Sovaldi surprise
 

Keywords :   


Insurers scrutinize drug costs after $84,000 Sovaldi surprise

2014-05-29 02:40:22| Biotech - Topix.net

Shocked by the rapid adoption of a new US$84,000 hepatitis C treatment, U.S. health insurers are trying to make sure they aren't blindsided by other drugs being developed and are looking for ways to limit their use from the day they are launched.

Tags: costs drug surprise insurers

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.06The Perils of Progress in the Search for New UV Filters
01.06This Interview Formality Jumpstarts Or Kills Your Chances Altogether
01.06Atlantic Tropical Weather Outlook
01.06Eastern North Pacific Tropical Weather Outlook
01.06You May Ask Yourself How Did We Get Here?
01.06Retinol Benefits With a Natural and Safe Alternative
01.06Tween Color Cosmetics Brand Talomi Puts a New Face on Beauty 
01.06How HCPA Racks Up Wins At State & Federal Levels
More »